JP2005301741A - Subject behavior confirmation system and drug container - Google Patents

Abstract

A subject behavior confirmation system is provided that can confirm whether a subject has taken a drug or the like according to a protocol.
A terminal device 20 and a server computer 10 exchange information with each other. The terminal device 20 is given to each subject and transmits a subject identification code S1 by the subject's operation. Receives the subject identification code S1 and transmits instruction information S2 indicating that any one of the medicine groups given in advance to the subject is to be administered, and the terminal device 20 receives the instruction information S2. Then, information S3 indicating that the subject has acted is transmitted to the server computer 10 based on the received instruction information S2.
[Selection] Figure 1

Description

  The present invention relates to a subject behavior confirmation system and a medicine container used in this system.

  For example, in a clinical trial of medicine (hereinafter sometimes referred to as clinical trial), a drug is administered to a subject to confirm the effectiveness of the medicine. Specifically, for example, after completion of a test using animals, the drug is administered to a small number of healthy subjects for confirmation (phase 1 test), and then the drug is applied to a small number of subjects having a predetermined disease. Is administered (phase 2 test), and the drug is administered to a large number of subjects having a predetermined disease (phase 3 test). In the Phase 1-3 trials, a clinical trial plan (hereinafter referred to as a protocol) has been established for each purpose. Need to be administered.

  In order to accurately administer the drug to the subject, it is most preferable to hospitalize the subject and administer the drug under the guidance of a doctor. For example, in the second and third phase tests, the subject is hospitalized. It is common to instruct the subject to take the drug according to the protocol in normal life without doing so.

  Therefore, in clinical trials that do not involve hospitalization, it is necessary to believe the subject's report (based on the goodness theory) as to whether or not the subject has taken the dosage / drug-protecting drug exactly as specified in the protocol. It was difficult to say that the validation (validation) was sufficient as to whether it was taken according to the protocol. For example, it was not supported whether or not the drug was actually taken, whether or not it was taken in a predetermined time, dose, and usage.

  In a clinical trial, if a drug is not taken according to the protocol, it will have serious consequences that overturn the credibility of the test results themselves and, in turn, will have serious consequences regarding the safety of the drug.

  For example, in Patent Literature 1 and Patent Literature 2, if the subject does not access the server within a predetermined period, the subject assumes that the subject did not take the medicine at the scheduled time, and the server takes the medicine to the subject. A system for instructing etc. is disclosed. Therefore, according to Patent Document 1 and Patent Document 2, it is possible to prevent a subject from forgetting to take a medicine.

However, Patent Document 1 and Patent Document 2 determine whether or not medicine is taken correctly based on only the fact that the subject has accessed the server, and the subject opens the medicine container that contains the medicine. There is no evidence as to whether or not the act of taking the drug was done correctly. For this reason, even when the systems of Patent Document 1 and Patent Document 2 are used, it is difficult to say that the validation is sufficient.
JP 2003-323497 A JP 2003-323489 A

  The subject of this invention is providing the test subject behavior confirmation system which can confirm whether a test subject took the chemical | medical agent etc. according to the protocol.

  Another object of the present invention is to provide a drug container suitable for the subject behavior confirmation system according to the present invention.

  In order to solve the above-described problems, the present invention discloses a subject behavior confirmation system.

  The subject behavior confirmation system according to the present invention includes a terminal device and a server computer.

  The terminal device and the server computer exchange information with each other.

  The terminal device is given to each subject and transmits a subject identification code by the subject's operation.

  The server computer receives the subject identification code and transmits instruction information indicating that any one of the medicine groups given in advance to the subject should be used.

  The terminal device receives the instruction information and transmits information indicating that the subject has acted based on the received instruction information to the server computer.

  The subject behavior confirmation system according to the present invention described above includes a terminal device and a server computer, and since the terminal device and the server computer exchange information with each other, a large amount of information can be processed accurately and quickly. . Information can be exchanged using, for example, a computer network. Examples of the computer network include the Internet and a local area network (LAN). It may be wired or wireless.

  The terminal device is given to each subject and transmits a subject identification code by the subject's operation. Examples of the subject identification code include the name of the subject, an identification number assigned to the subject, and the like.

  By receiving the subject identification code, the server computer can confirm that the person who transmitted the subject identification code is a previously registered subject. For this reason, it is possible to transmit to the subject instruction information to the effect that one of the medication groups given to the subject in advance should be used.

  The terminal device receives the instruction information and transmits information indicating that the subject has acted based on the received instruction information to the server computer. For this reason, the server computer can receive information indicating that the subject has acted based on the instruction information within a short period of time after transmitting the instruction information. You can check whether you acted.

  That is, in the present invention, the subject is allowed to take the medicine based on the instruction information. For example, the medicine to be taken is attached with a label corresponding to the instruction for taking the medicine and acted based on the instruction information. The information of the sign can be transmitted as information to that effect. For this reason, it is possible to confirm whether or not the subject has acted based on the instruction information by analyzing the information of the sign.

  For example, by analyzing the information of the marker, it can be confirmed whether or not the subject opened the medicine container containing the medicine or whether or not the subject took the correct medicine.

  In the present invention, since a dosing instruction is given immediately before drug administration, the subject cannot administer the drug before a predetermined time. For this reason, it is possible to prevent a situation in which a false report that a medicine has been administered before a predetermined time and a medicine has been administered at an accurate time is reported.

  Moreover, the chemical | medical agent container which concerns on this invention contains the chemical | medical agent and a label | marker. The medicine is housed inside, and the marker includes information on the medicine. For this reason, it can adapt to the subject action confirmation system mentioned above.

  Other features of the present invention and the operational effects thereof will be described in more detail by way of examples with reference to the accompanying drawings.

  FIG. 1 is a block diagram showing an outline of an embodiment of a subject behavior confirmation system according to the present invention. In the present invention, a drug is a substance having a wide chemical action. For example, a drug used for treatment / prevention of diseases and wounds, a functional food that nourishes and benefits the mind and body (health food, food for specified health use). Including cosmetics that may chemically affect the skin. Moreover, using a chemical | medical agent means the act which takes the chemical | medical agent, the action which applies a chemical | medical agent, the act which sticks a chemical | medical agent as a poultice, the action which inject | pours a chemical | medical agent (solution), etc. In the following description, “take” or “administration” is a concept that includes all the actions described above.

  The subject behavior confirmation system according to the present invention can be used, for example, to continuously administer a drug to a human for a certain period of time and to test the action and efficacy of the drug. Specifically, for example, for clinical trials of new drugs, bioequivalence tests of generic drugs, bioavailability tests, post-marketing surveillance of drugs, tests to confirm the effects of functional foods, cosmetics, etc. Can be used.

  For example, when the subject behavior confirmation system according to the present invention is used as a clinical trial for a new drug, it may be any of the first to third phases, and any of clinical pharmacological tests, exploratory tests, verification tests, and therapeutic tests But you can. In the present specification, “clinical trial” means testing the effect of treatment or testing the effect of a drug by a clinical trial, and is used synonymously with “clinical trial”.

  In FIG. 1, the illustrated subject behavior confirmation system includes a terminal device 20, a computer network 30, and a server computer 10. The server computer 10 and the terminal device 20 store each other's addresses, and can exchange information with each other via the computer network 30.

  The server computer 10 is a computer that provides its own functions and data to the terminal device 20 via the computer network 30. Specific examples of the server computer 10 include a workstation and a personal computer.

  The server computer 10 is, for example, a pharmaceutical company that develops a drug, a clinical trial facility support organization (SMO), a functional food company, a cosmetics company, a medical institution that uses a drug, a health center, a geriatric health facility, an esthetic salon, a beauty salon, It is provided under an organization or the like (hereinafter referred to as a tester) that acts according to these instructions.

  The terminal device 20 is a device that can be connected to the computer network 30 and can be operated by a subject in a drug administration test. Specific examples of the terminal device 20 include a desktop personal computer, a notebook personal computer, a mobile phone with a built-in microcomputer, and a portable information terminal such as a PDA (personal digital assistant).

  The terminal device 20 is provided in a place where the subject can operate. For example, when the terminal device 20 is a mobile phone, it is carried by a subject, and when it is a desktop personal computer, it is provided at the subject's home. The terminal device 20 may be loaned to the subject by the tester or may be owned by the subject.

  Next, the operation of the subject behavior confirmation system described above will be described. FIG. 2 is a flowchart showing an outline of an embodiment of the subject behavior confirmation system according to the present invention.

  As shown in FIG. 2, when using the subject behavior confirmation system shown in FIG. 1, the tester first creates a trial implementation plan (hereinafter referred to as a protocol) and recruits subjects based on the protocol. . The server computer 10 receives the contents of the protocol, the medicine distributed to the subject, the address of the terminal device 20 used by the subject, and the like. For example, when the drug is a functional food, cosmetics, etc., the protocol refers to, for example, a test execution plan for functional foods, cosmetics, etc.

  Next, the contents of the clinical trial are explained to the subject based on the protocol, the method of using the terminal device 20 used in the subject behavior confirmation system, etc. are explained, and the necessary drug group and the terminal device 20 are distributed. The

  For example, as a method of using the terminal device 20, the subject transmits the subject identification code S <b> 1 immediately before or at the time of drug administration, receives the instruction information S <b> 2 as a transmission result, and acts based on the received instruction information S <b> 2. Then, an explanation is sent that the information S3 indicating that the user has acted is transmitted to the server computer 10.

  Next, a drug administration (taking) test using the subject behavior confirmation system is executed. In the drug administration test, the subject first transmits the subject identification code S1 using the terminal device 20 at or just before the time of drug administration based on the protocol. In the illustrated embodiment, the drug administration time is, for example, that the study period is 3 days, and the drug is administered every day at 9:00, 12:00, and 17:00. The subject identification code S1 is, for example, the name and password of the subject.

  Next, the server computer 10 receives the subject identification code S1 and transmits instruction information S2 indicating that a specific medicine is to be taken from the medicine group given to the subject in advance.

  Next, the terminal device 20 receives the instruction information S2. The subject selects and takes a specific medicine out of the medicine group according to the instruction information S2, and uses the terminal device 20 to transmit information S3 indicating that he / she has acted based on the instruction information S2 to the server computer 10.

  Finally, the server computer 10 receives information S3 indicating that the user has acted based on the instruction information S2, and confirms whether or not the medicine has been taken correctly.

  The subject behavior confirmation system according to the present invention described above includes the terminal device 20 and the server computer 10, and since the terminal device 20 and the server computer 10 exchange information with each other, a large amount of information is processed accurately and quickly. can do. Information can be exchanged using, for example, a computer network. Examples of the computer network include the Internet and a local area network (LAN).

  The terminal device 20 is given to each subject, and transmits the subject identification code S1 by the subject's operation. The subject identification code S1 can include, for example, the name of the subject, an identification number assigned to the subject, and the like.

  The subject identification code S1 preferably includes not only a name and an identification number, but also an ID (identification) such as a password. This is because the following trial / drug administration is proved by the operation of the subject, not the other person posing as the subject.

  By receiving the subject identification code S1, the server computer 10 can confirm that the person who transmitted the subject identification code S1 is a registered subject. For this reason, instruction information S2 indicating that a specific medicine should be taken from a group of medicines given to the subject in advance can be transmitted to the subject.

  The terminal device 20 receives the instruction information S2, and transmits to the server computer 10 information S3 indicating that the subject has acted based on the received instruction information S2. Therefore, the server computer 10 can receive the information S3 indicating that the subject has acted based on the instruction information S2 within a short time after transmitting the instruction information S2. It can be confirmed whether or not the user has acted based on the information S2.

  That is, in the present invention, the subject is allowed to take the medicine based on the instruction information S2. For example, a label corresponding to the instruction for taking is given to the medicine to be taken, and the instruction information S2 is used. Information on the sign can be transmitted as information S3 indicating that the user has acted. For this reason, it is possible to confirm whether or not the subject has acted based on the instruction information S2 by analyzing the information of the sign.

  For example, by analyzing the information of the marker, it can be confirmed whether or not the subject opened the medicine container containing the medicine or whether or not the subject took the correct medicine.

  In the present invention, since a dosing instruction is given immediately before drug administration, the subject cannot administer the drug before a predetermined time. For this reason, it is possible to prevent a situation in which a false report that a medicine has been administered before a predetermined time and a medicine has been administered at an accurate time is reported.

  3 is a block diagram showing an outline of a server computer used in one embodiment of the subject behavior confirmation system according to the present invention, FIG. 4 is a diagram showing a drug container group according to the present invention, and FIG. 5 is a drug container shown in FIG. FIG. 6 is a view showing the sign shown in FIG. 5 in more detail.

  Hereinafter, the drug container according to the present invention and the subject behavior confirmation system shown in FIGS. 1 and 2 will be described in more detail with reference to FIGS.

  4 and 5, the drug container group according to the illustrated embodiment includes a plurality of drug containers 51 to 59. Each of the drug containers 51 to 59 has identifiers “NO.01” to “NO.09” for each drug container on the surface, and stores the signs 61 to 69 and the drugs 81 to 89. The medicine containers 51 to 59 are made of an opaque material, and the inside cannot be visually recognized before opening.

  The drugs 81 to 89 are a group of drugs given to the subject. In the embodiment shown in the figure, each medicine container 51-59 contains only the amount of medicine 81-89 required for a single dose. For example, the drugs 81 to 89 may all be the same drug, or at least one of the drugs 81 to 89 may be a pseudo drug having the same appearance, taste, and smell as the drug to be tested. This is because, for example, the psychological influence of the subject can be evaluated by administering the pseudo drug to the subject.

  The signs 61 to 69 include information corresponding to the medicines 81 to 89 stored in the same medicine container. In the figure, the signs 61 to 69 include a barcode that is image information that can be read by a machine, and a number that is image information that can be read by a subject. The signs 61 to 69 are not limited to image information, and may include electromagnetic information such as an IC tag, or may include infrared information.

  In FIG. 5, the indicator 64 includes information “1527884097”. The first two digits “15” are the trial identification number, the next two digits “27” are the subject number, the next two digits “84” are the drug numbers, the next two digits “09” are the unique numbers, and the next two digits “ 77 "is checksum information.

  The clinical trial identification number is a number corresponding to the clinical trial being conducted, and is common to all labels used in the same clinical trial. The subject number is a number corresponding to the name of the subject and is common to each subject. The drug number is a number corresponding to the drug or pseudo drug stored in the same drug container as the label, and for the labels 61, 62, 63, 64..., “81”, “82”, “ 83 ”,“ 84 ”... The unique number is a number provided so that the signs are not the same. For example, for the signs 61, 62, 63, 64..., “09”, “03”, “07”, “01”. .. May be a random number such as “01”, “02”, “03”, “04”... The checksum is a number for confirming that data has been transmitted without error. For example, the checksum can be set so that the sum of each digit of the sign becomes a constant value. In FIG. 5, the indicator 64 is the sum of each digit (“1” + “5” + “2” + “7” + “8” + “4” + “0” + “9” + “7” + “ The checksum is set to “77” so that 7 ”= 50) is 50.

  3, the server computer 10 includes a CPU (central processing unit) 91, an input / output unit 92, a clinical trial information table 93, a subject information table 94, and a clinical trial drug distribution table 95.

  For example, the server computer 10 stores information on the clinical trial implementation plan (protocol) in the clinical trial information table 93, and stores the name, password, health status, etc. of the subject in the subject information table 94 and distributes it to the subject. The drug group, the identifier of the drug container, the drug stored in the drug container, the correspondence between the labels, and the like can be stored in the study drug distribution table 95.

  For example, in the server computer 10, the medicines 81 to 89 and the signs 61 to 69 are recorded in which medicine containers 51 to 59 are stored. That is, the server computer 10 stores the medicine 81 and the label 61 in the medicine container 51 with the identifier “NO.01”, and the medicine 82 and the sign 62 in the medicine container 52 with the identifier “NO.02”. The medicine 83 and the label 63 are stored in the medicine container 53 stored with the identifier “NO.03”, and the medicine 84 and the label 64 are stored in the medicine container 54 with the identifier “NO.04”. Drug 85 and label 65 are stored in drug container 55 labeled “NO.05”, drug 86 and label 66 are stored in drug container 56 labeled “NO.06”, and identifier “NO.07” is stored. The drug 87 and the label 67 are stored in the drug container 57 marked with “”, the drug 88 and the label 68 are stored in the drug container 58 labeled with the identifier “NO.08”, and the identifier “NO.09” is Information indicating that the drug 89 and label 69 to the medicament container 59 is housed is recorded.

  Thereby, the CPU 91 of the server computer 10 can appropriately access the clinical trial information table 93, the subject information table 94, and the clinical trial drug distribution table 95 to execute the arithmetic processing.

  Hereinafter, with reference to FIGS. 2 to 6, a drug administration test using the illustrated subject behavior confirmation system will be described in detail.

  First, the subject uses the terminal device 20 to transmit the subject identification code S1. The subject identification code S1 includes, for example, information on the subject number “27” and a password.

  Next, the server computer 10 receives the subject identification code S1 and records the received date and time. Thereafter, the server computer 10 determines whether or not the sender of the subject identification code S1 is a person recorded in the subject information table 94 and the drug administration whose transmission of the subject identification code S1 is recorded in the clinical trial information table 93. It is determined whether or not it was performed at the date and time. And when it judges that it is appropriate, based on the clinical trial information table 93, the clinical trial drug distribution table 95, and the test subject information table 94, it is indicated that a specific medicine should be administered from the medicine group given to the subject beforehand. Instruction information S2 is transmitted.

  In the illustrated embodiment, the server computer 10 uses, as the instruction information S2, information corresponding to the identifiers “NO.01” to “NO.09” of the medicine containers 51 to 59 that contain the medicines 81 to 89 to be taken this time. Send. In the illustrated embodiment, the instruction information S2 includes information corresponding to the identifier “NO. 04” of the medicine container 54 that contains the medicine 84 to be taken this time.

  Next, the terminal device 20 receives the instruction information S2. The subject opens the medicine container 54 with the identifier “NO.04” according to the instruction information S2, and takes out the medicine 84 and the marker 64. Thereby, the test subject has selected a specific drug 84 from the drugs 81-89.

  Next, the subject takes the medicine 84 and transmits the information “1527840977” of the sign 64 to the server computer 10 using the terminal device 20. As a result, the subject has transmitted to the server computer 10 information S3 indicating that he has acted based on the instruction information.

  In the illustrated embodiment, since the sign 64 includes bar code information, the subject can send the information “1527840977” of the sign 64 to the server computer 10 by scanning the bar code of the sign 64. In addition, since the sign 64 includes numeric information, the information “1527840977” of the sign 64 can be transmitted to the server computer 10 by using an operation button of a mobile phone or the like when there is a problem with the barcode reader.

  At this time, it is preferable to transmit subject identification code S1, a password, and the like together with information S3 indicating that the user has acted. This is because it can be proved that the terminal device 20 has been operated by the subject, not by the other person posing as the subject.

  The server computer 10 receives the information S3 indicating that the user has acted based on the instruction information, and records the received date and time. Thereafter, the server computer 10 determines the behavior of the subject. Specifically, for example, the server computer 10 corresponds to the medicine 84 stored in the medicine container 54 in the fifth and sixth digits from “1527840977” included in the information S3 indicating that the user has acted. Since it is “84”, it is determined that the subject has taken the medicine 84.

  Next, the server computer 10 compares the information in the clinical trial information table 93, the clinical trial drug distribution table 95, and the subject information table 94 with information S3 indicating that the subject has acted, so that the subject correctly administers the drug according to the protocol. Make sure you did. Specifically, for example, instruction information S2 indicating that the medicine 84 should be taken is recorded in the information table, and the medicine 84 indicated by the instruction information S2 matches the medicine 84 taken by the subject. Verify that the correct medication was administered according to the protocol.

  On the other hand, for example, when the fifth digit and the sixth digit of the information S3 indicating that the user has acted are “81”, the server computer 10 determines that the subject has received the identifier “NO.01” due to the mistake of the subject. It is determined that the container 51 is opened, the medicine 81 is taken, and the information “1527810900” of the sign 61 is transmitted. In this case, the server computer 10 compares the information in the information table to confirm that the subject is not correctly administering the drug according to the protocol. Thereby, the server computer 10 can take appropriate measures such as notifying the doctor that the subject has taken the medicine 81 by mistake.

  For example, unlike functional foods and the like, drugs used for cancer treatment and the like generally have a strong chemical action, and may have a serious effect on the human body if they are not taken correctly according to the protocol. The subject behavior confirmation system of the embodiment shown in the figure, for example, when testing a drug, if the subject takes a wrong dose, can confirm the fact that the subject has taken it in an early stage and can take an appropriate response. This will have a remarkable effect on ensuring safety.

  Further, in the illustrated embodiment, the server computer 10 records the date and time when the subject identification code S1 transmitted by the subject is received, and the date and time when the information S3 indicating that the user has acted based on the instruction information is received. Therefore, by comparing these pieces of information with information in the information table, it can be confirmed whether or not the subject is administering the drug at the correct time according to the protocol. In the subject behavior confirmation system according to the present invention, only the reception date / time of the subject identification code S1 or the reception date / time of the information S3 indicating that the user has acted based on the instruction information is recorded, and the drug is administered at the correct time. It can also be confirmed whether or not.

  In the illustrated embodiment, the server computer 10 warns the subject when he / she does not receive the subject identification code S1 or the information S3 indicating that he / she has acted based on the instruction information at the reception date / time determined by the protocol. Can be encouraged to administer drugs.

  In the illustrated embodiment, the drug containers 51 to 59 are opaque drug containers, and the inside cannot be visually confirmed before opening. Therefore, when the information of the signs 61 to 69 stored in the medicine container is transmitted to the server computer 10, sufficient validation can be obtained that the subject opens the medicine containers 51 to 59.

  In addition, since the medicine containers 51 to 59 are opened, it can be inferred that the subject takes the medicine, except in a special case where the subject intentionally makes a false report. Therefore, sufficient validation can be obtained about the subject taking the medicine.

  Further, in the subject behavior confirmation system of the illustrated example, since the subject transmits the subject identification code S1 to the server computer 10 using the terminal device 20 before drug administration, the subject is alerted and the drug is administered. It is possible to prevent the situation of forgetting the time.

In the subject behavior confirmation system according to the present invention, information S3 indicating that the user has acted based on the instruction information includes information on whether or not the correct medicine has been taken, and information on whether or not the medicine has been administered at the correct time. It is not limited to. The subject behavior confirmation system according to the present invention also determines whether or not there is an error in the dosage or usage of other drug administration by selecting appropriate information as information S3 indicating that the user has acted based on the instruction information. FIG. 7 is a block diagram showing an outline of a server computer used in another embodiment of the subject behavior confirmation system according to the present invention. In the figure, the same components as those shown in FIGS. 1 to 6 are denoted by the same reference numerals, and redundant description is omitted.

  The illustrated subject behavior confirmation system includes a medication time reference table 96 in addition to the configuration of the server computer 10 described with reference to FIGS. In the medication time reference table 96, the point corresponding to the error between the correct reception date and time and the actual reception date and time according to the protocol for the subject identification code S1 or the information S3 indicating that the action is performed based on the instruction information Is recorded. For example, the medication time reference table 96 is set so that the smaller the error from the taking reference time, the higher the score. In the embodiment shown in the drawing, if the reference time is ± 10 minutes, the reward point is 10 points, if the reference time is ± 20 minutes, the reward point is 5 points, and if the reference time is ± 30 minutes, the reward point is 1 point. It is prescribed as follows.

  The illustrated subject behavior confirmation system, like the subject behavior confirmation system described with reference to FIGS. 1 to 6, transmits / receives the subject identification code S <b> 1, transmits / receives the instruction information S <b> 2, and indicates that the user has acted based on the instruction information. Information S3 is transmitted and received, and the reception date and time of the subject identification code S1 is recorded.

  Next, the CPU 91 of the server computer 10, for example, assumes that the drug administration time defined by the protocol is 9:00, and if the reception date and time of the subject identification code S1 is 9:05, the drug administration time ± 10 And 10 reward points are added to the subject information table 94. Similarly, if the reception date / time is the drug administration time ± 20 minutes, 5 reward points are added, and if the reception date / time is the drug administration time ± 30 minutes, 1 reward point is added.

  Then, when the reward points recorded in the subject information table 94 become a reference value, for example, 50 points or more, the CPU 91 of the server computer 10 uses the terminal device 20 to give the subject a prize, prize money, etc. Notify that you can receive

  Further, in the subject behavior confirmation system according to the present invention, only the reception date and time of the information S3 indicating that the user has acted based on the instruction information, or the information S3 indicating that the user has acted based on the subject identification code S1 and the instruction information. Needless to say, reward points may be added using both reception dates and times.

  In the illustrated subject behavior confirmation system, it is possible to easily perform performance management of whether or not drug administration has been performed at an accurate time with reference to the drug administration time determined by the protocol. Moreover, prizes, prize money, etc. can be given to the subject who has correctly administered the medicine at the correct time in conjunction with the results.

  Further, in the illustrated subject behavior confirmation system, awarding a prize, a prize money, or the like is an incentive, and the subject takes an appropriate behavior, so that the quality of the test data is improved.

  Moreover, since the illustrated subject behavior confirmation system has the same components as those of the subject behavior confirmation system illustrated in FIGS. 1 to 6, the same operational effects can be achieved.

  FIG. 8 is a diagram for explaining still another embodiment of the subject behavior confirmation system according to the present invention. In the illustrated subject action confirmation system, the signs 61 to 69 are printed on the cases of the drugs 81 to 89. In the figure, the medicines 81 to 89 are printed on the front surface of the case, but may be printed on the back surface.

  Since the illustrated subject behavior confirmation system has the same components as those of the subject behavior confirmation system illustrated in FIGS. 1 to 7, the same effects can be achieved.

  FIG. 9 is a diagram for explaining still another embodiment of the subject behavior confirmation system according to the present invention. In the illustrated subject action confirmation system, the signs 61 to 69 are printed on the cases of the drugs 81 to 89. In addition, the signs 61 to 69 and the drugs 81 to 89 are stored in one drug container 51.

  In the illustrated subject behavior confirmation system, a single medicine container 51 contains a quantity of medicines 81 to 89 used for two or more doses, but is similar to the subject behavior confirmation system shown in FIGS. Since it has a component, there can exist the same effect.

  FIG. 10 is a diagram for explaining still another embodiment of the subject behavior confirmation system according to the present invention. In the illustrated subject behavior confirmation system, there is one kind of medicine 81. One sign 61 is printed on the case of the medicine 81.

  The illustrated subject behavior confirmation system cannot distinguish between drugs because there is one label 61, but has the same components as the subject behavior confirmation system shown in FIGS. The effect of this can be achieved.

  FIG. 11 is a diagram for explaining still another embodiment of the subject behavior confirmation system according to the present invention. In the illustrated subject behavior confirmation system, the marker 61 is printed on one medicine container 51.

  Since the illustrated subject behavior confirmation system has the same components as those of the subject behavior confirmation system shown in FIGS. 1 to 10, the same operational effects can be achieved.

  Although the contents of the present invention have been specifically described with reference to the preferred embodiments, it is obvious that those skilled in the art can take various modifications based on the basic technical idea and teachings of the present invention. It is.

It is a block diagram which shows the outline of one Example of the test subject action confirmation system which concerns on this invention. It is a flowchart which shows the outline of one Example of the test subject action confirmation system which concerns on this invention. It is a block diagram which shows the outline of the server computer used for one Example of the test subject action confirmation system which concerns on this invention. It is a figure which shows the chemical | medical agent container group which concerns on this invention. It is a figure which shows the chemical | medical agent container shown in FIG. 4 in detail. It is a figure which shows the label | marker shown in FIG. 5 in detail. It is a block diagram which shows the outline of the server computer used for another one Example of the test subject action confirmation system which concerns on this invention. It is a figure explaining another one Example of the test subject action confirmation system which concerns on this invention. It is a figure explaining another one Example of the test subject action confirmation system which concerns on this invention. It is a figure explaining another one Example of the test subject action confirmation system which concerns on this invention. It is a figure explaining another one Example of the test subject action confirmation system which concerns on this invention.

Explanation of symbols

20 Terminal device 10 Server computer S1 Subject identification code S2 Instruction information S3 Information indicating action based on instruction information

Claims (6)

A subject behavior confirmation system including a terminal device and a server computer,
The terminal device and the server computer exchange information with each other,
The terminal device is given to each of the subjects, transmits a subject identification code by the subject's operation,
The server computer receives the subject identification code, and transmits instruction information indicating that one of the medicine groups given to the subject in advance should be used,
The terminal device receives the instruction information, and transmits information indicating that the subject has acted based on the received instruction information to the server computer. The subject behavior confirmation system according to claim 1,
Each of the drugs included in the drug group is stored in a drug container,
Each of the drug containers has an identifier for each drug container,
The instruction information is a subject behavior confirmation system including information on the identifier. The subject behavior confirmation system according to claim 2,
Each of the drug containers contains a sign,
The sign includes information on the drug stored together in the drug container;
The terminal device is a subject behavior confirmation system that transmits information on the sign to the server computer as information indicating that the subject has acted. The subject behavior confirmation system according to any one of claims 1 to 3,
The server computer stores a date and time when the subject identification code is received and a date and time when information indicating that the subject has acted is received. The subject behavior confirmation system according to claim 4,
The server computer compares at least one of the reception dates and times with the date and time to be received specified in a protocol, and adds a point corresponding to an error between the date and time to be received to the subject. Confirmation system. A drug container used in the subject behavior confirmation system,
Containing a drug and a label,
The medicine is housed inside,
The said label | marker is the chemical | medical agent container containing the information of the said chemical | medical agent.

Images